IVS ITF (commonly referred to as “IVS”)

The IVS ITF, established in February 2002 under the IFPMA Biologicals and Vaccines Committee, represents 15 research-based vaccine manufacturers from around the world. IVS members produce most of the world’s influenza vaccines and conduct the R&D necessary to develop and produce safe, effective, high-quality human vaccines to protect against seasonal and pandemic influenza.

IIPT

The International Institute For Peace Through Tourism (IIPT) is a not for profit organization dedicated to fostering and facilitating tourism initiatives which contribute to international understanding and cooperation, an improved quality of environment, the preservation of heritage, and through these initiatives, helping to bring about a peaceful and sustainable world.

IHR

The International Health Regulations (2005) are a legally binding instrument of international law that aim to a) assist countries to work together to save lives and livelihoods endangered by the international spread of diseases and other health risks, and b) avoid unnecessary interference with international trade and travel.

IHME

The Institute for Health Metrics and Evaluation is a research institute working in the area of global health statistics and impact evaluation at the University of Washington in Seattle.

IDB

The Inter-American Development Bank is the largest source of development financing for Latin America and the Caribbean.

IPRF

Purpose:
The purpose of the International Pharmaceutical Regulators Forum (IPRF) is to create an environment for pharmaceutical regulators to exchange of information on issues of mutual concern and regulatory cooperation.

IGDRP

The International Generic Drug Regulators Programme (IGDRP) was created to promote collaboration and convergence in generic drug regulatory programs in order to address the challenges posed by increasing workloads, globalisation and complexity of scientific issues.

ICMRA

International Coalition of Medicines Regulatory Authorities (ICMRA) is a voluntary, executive-level, strategic coordinating, advocacy and leadership entity of regulatory authorities that work together to:
-address current and emerging human medicine regulatory and safety challenges globally, strategically and in an on- going, transparent, authoritative and institutional manner
-provide direction for areas and activities common to many regulatory authorities' missions
-identify areas for potential synergies

ICH

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of drug registration. Since its inception in 1990, ICH has gradually evolved, to respond to the increasingly global face of drug development. ICH's mission is to achieve greater harmonisation worldwide to ensure that safe, effective, and high quality medicines are developed and registered in the most resource-efficient manner.

ICDRA

The International Conference of Drug Regulatory Authorities (ICDRAs) provide drug regulatory authorities of WHO Member States with a forum to meet and discuss ways to strengthen collaboration. The ICDRAs have been instrumental in guiding regulatory authorities, WHO and interested stakeholders and in determining priorities for action in national and international regulation of medicines, vaccines, biomedicines and herbals.